Global DTaP and Tdap Vaccines Market Analysis Covers Industry Data 2020 by Types, Applications, Size and Share Forecast by Regions 2026

Global “DTaP and Tdap Vaccines Market” report includes the competition landscape involving share analysis of the key players in the DTaP and Tdap Vaccines market based on their revenues and other significant factors. DTaP and Tdap Vaccines market trend report is one of the most comprehensive and important additions to research studies. It offers detailed research and analysis of key aspects of the global DTaP and Tdap Vaccines market share. The report investigates DTaP and Tdap Vaccines market size, share, trends, development plans, growth, driver’s analysis, investment plan, and cost structure.

Get a Sample Copy of the Report At - https://www.industryresearch.co/enquiry/request-sample/15387295

About DTaP and Tdap Vaccines Market:

Pertussis vaccine is used for whooping cough. This vaccine is available only in combination with other vaccines. Pertussis vaccination is recommended for all children, babies, teens, and pregnant women. Diphtheria, tetanus, and pertussis (DTaP) vaccines are given to children younger than seven years old, while tetanus, diphtheria, and pertussis (Tdap) vaccines are given to older children and adults. Childhood vaccination is one of the safest and cost-effective ways for pertussis-free environment. The World Health Organization (WHO) and Centers for Disease Control and Prevention (CDC) recommend all children should be routinely vaccinated for pertussis. According to WHO in 2015, about 86% of infants received three doses of diphtheria-tetanus-pertussis (DTP3) vaccine worldwide to protect them against infectious diseases. In 2015, procurement of DTwP vaccine through UNICEF had reached 5.8 million doses for 18 countries and territories out of which four countries such as Egypt, Morocco, Uzbekistan, and Zimbabwe accounted for more than 80% of UNICEF’s total procurement.

Factors such as high birth rate, increase in number of geriatric population, government initiatives, growth in adoption of pertussis vaccination, and government insurance and reimbursement scenario are projected to drive the pertussis vaccine market globally. According to WHO in 2015, 126 countries had reached at least 90% coverage of diphtheria-tetanus-pertussis vaccine. On the other hand, factors such as vaccine injuries and adverse event are expected to hinder the growth of the pertussis vaccine market globally. In the U.S. in 2015, there had been 7 claims filed in the federal Vaccine Injury Compensation Program (VICP) for injuries and deaths following pertussis vaccination, including three deaths and four serious injuries.

The pertussis vaccine market has been segmented by product type, vaccine type, age group, end-user, and geography. In terms of product type, the pertussis vaccine market is classified into DTaP vaccine and Tdap vaccine. The DTaP vaccine segment includes products such as Daptacel, Infanrix, Kinrix, Pediarix, Pentacel, and Quaracel. The Tdap vaccine segment comprises products such as Boostrix and Adacel. In terms of vaccine type, the pertussis vaccine market is classified into whole-cell vaccine and acellular vaccine. The acellular vaccine segment is highly used owing to less side effect. The acellular vaccine is about 71%–85% effective, whereas whole-cell vaccine is about 78% effective. In terms of age group, the pertussis vaccine market is classified into adult and pediatric. In terms of end-user, the market is classified into hospitals, clinics, and vaccination centers. Geographically, the pertussis vaccine market is classified into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

North America dominates the pertussis vaccine market due to growth in number of geriatric population and increase in pertussis death rate in the U.S, which drive the pertussis vaccine market. In 2014, according to the CDC, 28,660 cases of pertussis were reported in the U.S. The North America market is followed by the Europe and Asia Pacific markets. Asia Pacific is expected to grow at a higher rate due to rapid population growth, increase in adoption for vaccination, and growth in prevalence of infectious disease. These factors are expected to fuel the pertussis vaccine market. In the Asia Pacific region, Thailand accounts for 99% in pertussis vaccine coverage, followed by Japan and China with 98% and 97%, respectively. Developing countries such as Brazil, South Africa, and Mexico are estimated to create good opportunity for the pertussis vaccine market growth attributing to rise in number of government and private health care insurance coverage, increase in health care expenditure, and growth in awareness among people.

The global DTaP and Tdap Vaccines market is valued at US$ xx million in 2020 is expected to reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2021-2026.

This report focuses on DTaP and Tdap Vaccines volume and value at the global level, regional level and company level. From a global perspective, this report represents overall DTaP and Tdap Vaccines market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.

DTaP and Tdap Vaccines Market Covers Manufacturers:

Sanofi Pasteur
GlaxoSmithKline
Protein Sciences Corporation
Novartis AG
Seqirus
Merck Sharp & Dohme Corp
Astellas Pharma US, Inc
Pfizer Inc
Johnson & Johnson
Lanzhou Institute of Biological Products Co., Ltd
AstraZeneca
Emergent BioSolutions Inc

DTaP and Tdap Vaccines Market Production by Regions:

United States
Europe
China
Japan
South Korea

DTaP and Tdap Vaccines Market report consumption with respect to other regions like Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Malaysia, Philippines, Thailand, Vietnam, Europe, Germany, France, UK, Italy, Russia.

Inquire or Share Your Questions If Any Before the Purchasing This Report -https://www.industryresearch.co/enquiry/pre-order-enquiry/15387295

DTaP and Tdap Vaccines Market by Types:

DTaP
Td
Tdap

DTaP and Tdap Vaccines Market by Applications:

Adult
Pediatric

Reasons for Buying DTaP and Tdap Vaccines Market Report:

This report provides pin-point analysis for changing competitive dynamics
It provides a forward looking perspective on different factors driving or restraining DTaP and Tdap Vaccines market growth
It provides a six-year forecast assessed on the basis of how the market is predicted to grow
It helps in understanding the key product segments and their future
It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Purchase this Report (Price 2900 USD for a Single-User License) - https://www.industryresearch.co/purchase/15387295

The study objectives of this report are:

To analyze global DTaP and Tdap Vaccines status, future forecast, growth opportunity, key market and key players.
To present the DTaP and Tdap Vaccines development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

DTaP and Tdap Vaccines Market TOC Covers the Following Points:

1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Players Covered: Ranking by DTaP and Tdap Vaccines Revenue

1.4 Market Analysis by Type

1.5 Market by Application

1.6 Study Objectives

1.7 Years Considered

2 Global Growth Trends by Regions

2.1 DTaP and Tdap Vaccines Market Perspective (2015-2026)

2.2 DTaP and Tdap Vaccines Growth Trends by Regions